Healthcare Industry News: Cappella
News Release - December 20, 2010
Cappella Medical Systems Announces First Placements of its New Dual Marker Sideguard(R) SystemGALWAY, Ireland--(Healthcare Sales & Marketing Network)-- Cappella Medical Systems has announced the successful initial placements of its new dual-marker Sideguard® coronary sidebranch stent system by Dr. Antonio Colombo and Dr. Azeem Latib at San Raffaele Hospital in Milan, Italy.
The Cappella Sideguard system is a self-expanding trumpet shaped nitinol stent designed to optimize treatment of bifurcation lesions. The novel, low-profile balloon-catheter delivery system includes proprietary split-sheath technology that helps ensure precise placement. Now, with the introduction of the new dual-marker system, clinicians will have an additional reference point to help visualize the position of the Sideguard system under angiography prior to deployment.
Commenting on the new dual marker Sideguard placement, Dr. Azeem Latib stated, “The additional reference marker is a nice addition to the Sideguard system. The angiographic view that produces the least amount of foreshortening between the two reference markers is helpful and ensures proper placement of the Sideguard system.”
The new Sideguard system with dual reference markers is CE mark approved and available for sale outside of the US. For additional information please visit www.Cappella-med.com.
About Cappella Medical Systems
Cappella, Inc. develops novel solutions for the treatment of complex coronary artery disease (CAD) - specifically bifurcation disease. Cappella’s Sideguard® coronary sidebranch technology offers interventional cardiologists a straightforward, effective, solution that focuses on treating the sidebranch of diseased coronary arteries first, rather than the main vessel. Clinicians can then use their preferred stent of choice in the main vessel. The Sideguard delivery system features an innovative split-sheath, balloon released, technology that ensures precise placement on the ostial borderline. The Sideguard self-expanding, nitinol, stent promotes continuous wall apposition and positive remodeling and its’ unique trumpet-shaped design conforms to varying characteristics of the sidebranch ostium. Cappella Medical Devices Ltd., Galway, Ireland is the R&D and manufacturing subsidiary of Cappella, Inc. For more information, please visit the Cappella Medical Systems website at www.Cappella-med.com.
Issuer of this News Release is solely responsible for its
Please address inquiries directly to the issuing company.